| | Title | Authors / Editors | Date |
|
unige:94186 |
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease |
Nordberg, Agneta; Carter, Stephen F; Rinne, Juha; Drzezga, Alexander; ... Herholz, Karl |
2013 |
|
unige:48292 |
Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI. |
Caroli, Anna; Prestia, Annapaola; Wade, Sara; Chen, Kewei; ... Frisoni, Giovanni |
2014 |
|
unige:94308 |
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework |
Garibotto, Valentina; Herholz, Karl; Boccardi, Marina; Picco, Agnese; ... Ratib, Osman |
2017 |
|
unige:94309 |
Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework |
Chiotis, Konstantinos; Saint-Aubert, Laure; Boccardi, Marina; Gietl, Anton; ... Nordberg, Agneta |
2017 |
|
unige:112287 |
Clinical validity of presynaptic dopaminergic imaging with 123I-ioflupane and noradrenergic imaging with 123I-MIBG |
Sonni, Ida; Ratib, Osman; Boccardi, Marina; Picco, Agnese; ... Varrone, Andrea |
2017 |
|
unige:114045 |
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease |
Drzezga, Alexander; Altomare, Daniele; Festari, Cristina; Arbizu, Javier; ... Boccardi, Marina |
2018 |
|
unige:140838 |
Harmonization of neuroimaging biomarkers for neurodegenerative diseases: A survey in the imaging community of perceived barriers and suggested actions |
Jovicich, Jorge; Barkhof, Frederik; Babiloni, Claudio; Herholz, Karl; ... Frisoni, Giovanni |
2019 |
Herholz, Karl
add all
remove all
